Library — CHDR

Search

Filter

Quantification of heparin-induced TFPI release: a maximum release at low heparin dose.

Kemme MJ, Burggraaf J, Schoemaker RC, Kluft C, Cohen AF

British journal of clinical pharmacology, 2002 Dec; 54(6):627-34

View publication
Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patients.

de Visser SJ, van der Post JP, Nanhekhan L, Schoemaker RC, Cohen AF, van Gerven JM

Clinical pharmacology and therapeutics, 2002 Oct; 72(4):419-28

View publication
Development of an optimal furosemide infusion strategy in infants with modeling and simulation.

Schoemaker RC, van dDer Vorst MM, van Heel IR, Cohen AF, Burggraaf J,

Clinical pharmacology and therapeutics, 2002 Oct; 72(4):383-90

View publication
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.

Faaij RA, Burggraaf J, Schoemaker RC, Van Amsterdam RG, Cohen AF

British journal of clinical pharmacology, 2002 Sep; 54(3):304-8

View publication
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants.

Kemme MJ, Faaij RA, Schoemaker RC, Kluft C, Meijer P, Cohen AF, Burggraaf J

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2001 Sep; 12(7):583-91

View publication
No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteers.

Kemme MJ, Burggraaf J, Schoemaker RC, Cohen AF

Thrombosis research, 2001 Jul; 103(1):9-16

View publication
Sympathovagal imbalance in hyperthyroidism.

Burggraaf J, Tulen JH, Lalezari S, Schoemaker RC, De Meyer PH, Meinders AE, Cohen AF, Pijl H

American journal of physiology. Endocrinology and metabolism, 2001 Jun; 281(1):E190-5

View publication
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.

Burggraaf J, Westendorp RG, in't Veen JC, Schoemaker RC, Sterk PJ, Cohen AF, Blauw GJ

Thorax, 2001 Jun; 56(7):567-9

View publication
Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.

de Visser SJ, van Gerven JM, Schoemaker RC, Cohen AF

British journal of clinical pharmacology, 2001 May; 51(5):423-8

View publication

«
1
2
...
5
6
7
8
9
10
11
12
13
»